|
1) Goodwin JF, Gordon H, Hollman A, et al. Clinical aspects of cardiomyopathy. Br Med J. 1961; 1: 69-79
|
|
|
|
|
2) Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990; 62: 999-1006
|
|
|
|
|
3) Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996; 93: 841-2
|
|
|
|
|
|
4) Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006; 113: 1807-16
|
|
|
|
|
|
5) Thiene G, Corrado D, Basso C. Revisiting definition and classification of cardiomyopathies in the era of molecular medicine. Eur Heart J. 2008; 29: 144-6
|
|
|
|
|
|
6) Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008; 29: 270-6
|
|
|
|
|
|
7) 北畠 顕, 友池仁暢, 編. 心筋症 診断の手引きとその解説. 厚生労働省難治性疾患克服研究事業 特発性心筋症調査研究班. 2005年11月
|
|
|
|
|